WUWEIZISU C
|
|
- CAS-Nr.
- 61301-33-5
- Englisch Name:
- WUWEIZISU C
- Synonyma:
- WUWEIZISU C;,8-dimethyl-;SCHIZANDRIN C;Schizandrin C-RM;(S)-(-)-Schisandrin C;WUWEIZISU C USP/EP/BP;Schisandrin C >=98% (HPLC);Schisandrin C (Schizandrin-C;Schisandrin C
(S)-(-)-Schisandrin C;13,14-dimethoxy-6,7-dimethyl-5,6,7,8-tetrahydro[1,3]benzodio...
- CBNumber:
- CB2327435
- Summenformel:
- C22H24O6
- Molgewicht:
- 384.42
- MOL-Datei:
- 61301-33-5.mol
|
WUWEIZISU C Eigenschaften
- Schmelzpunkt:
- 122-123℃
- Siedepunkt:
- 549.2±50.0 °C(Predicted)
- Dichte
- 1.232
- L?slichkeit
- DMSO : 8.33 mg/mL (21.67 mM; Need ultrasonic)H2O : < 0.1 mg/mL (insoluble)
- Aggregatzustand
- powder
- Farbe
- White
- LogP
- 5.623 (est)
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
WUWEIZISU C Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
Schisandrin C is a lignan originally isolated from
Schizandrae that has diverse biological activities. It decreases viability of U937 cells in a concentration-dependent manner and induces cell cycle arrest at the G
1 phase when used at a concentration of 100 μM. Schisandrin C (5-20 μM) decreases hydrogen peroxide-induced cell death and production of reactive oxygen species (ROS) in C2C12 skeletal muscle cells. It also decreases levels of matrix metalloproteinase-2 (MMP-2), MMP-9, COX-2, VCAM-1, IL-1β, and TNF-α in hydrogen peroxide-stimulated C2C12 cells. Schisandrin C decreases lipoteichoic acid-induced production of nitric oxide (NO), prostaglandin E
2 (PGE
2; ), TNF-α, IL-1β, and IL-6 in mouse primary microglia.
In vivo, schisandrin C (200 mg/kg) decreases serum alanine amino transferase (ALT) and aspartate amino transferase (AST) activity, increases hepatic mitochondrial and total glutathione (GSH) levels, and reduces liver injury in a mouse model of acetaminophen-induced liver injury partially
via inhibition of the cytochrome P450 (CYP) isoforms CYP2E1, CYP1A2, and CYP3A11.
Verwenden
Schisandrin C potently inhibits proprotein convertase subtillsin-kexin type 9 (PCSK9) mRNA expression. Also, it displays strong protective effects in SH-SY5Y cells against serum and glucose deprivation (SGD) injury.
WUWEIZISU C Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
WUWEIZISU C Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 181)Lieferanten
61301-33-5()Verwandte Suche:
- SCHIZANDRIN C
- WUWEIZISU C
- ,8-dimethyl-
- cycloocta(1,2-f:3,4-f’)bis(1,3)benzodioxole6,7,8,9-tetrahydro-1,13-dimethoxy-7
- (6R,7S,13aS)-5,6,7,8-Tetrahydro-13,14-dimethoxy-6,7-dimethylcycloocta[1,2-f:3,4-f']bis[1,3]benzodioxole
- (S)-(-)-Schisandrin C
- Schisandrin C
(S)-(-)-Schisandrin C
- 13,14-dimethoxy-6,7-dimethyl-5,6,7,8-tetrahydro[1,3]benzodio...
- WUWEIZISU C USP/EP/BP
- Schisandrin C >=98% (HPLC)
- Cycloocta[1,2-f:3,4-f']bis[1,3]benzodioxole, 5,6,7,8-tetrahydro-13,14-dimethoxy-6,7-dimethyl-, (6R,7S,13aS)-
- Schisandrin C (Schizandrin-C
- (6R,7S)-13,14-Dimethoxy-6,7-dimethyl-5,6,7,8-tetrahydro[1,3]benzodioxolo[5',6':3,4]cycloocta[1,2-f][1,3]benzodioxole
- Schizandrin C-RM
- 61301-33-5
- C22H24O6
- chemical reagent
- pharmaceutical intermediate
- phytochemical
- reference standards from Chinese medicinal herbs (TCM).
- standardized herbal extract
- Miscellaneous Natural Products